医渡科技(02158)今日盘中大涨7.66%,引起了市场的广泛关注。这与政策利好消息密切相关。
资讯披露,人工智能辅助诊断首次被列入国家医保报销范围的立项指南,这为公司旗下的AI医疗产品YiduCore带来了巨大的市场机遇。作为国内AI医疗行业的领军企业,医渡科技在人工智能大脑和智能诊断系统领域处于领先地位,此前已覆盖临床、影像、基因等多个场景。
分析人士认为,随着人工智能技术在医疗领域的渗透和应用,医渡科技有望凭借智能诊断和AI医疗大脑两大核心优势,抓住政策机遇期,实现核心业务的进一步增长。投资者对公司的长期增长前景更加看好,因此推动了今日股价的大涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.